Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v10-FR
Language French French
Date Updated 2017-11-16 2017-09-15
Drug Identification Number 02237821 02237821
Brand name AMERGE AMERGE
Common or Proper name naratriptan hydrochloride tablets naratriptan hydrochloride tablets
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients NARATRIPTAN NARATRIPTAN
Strength(s) 2.5MG 2.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 6's 6's
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-09-15 2017-09-15
Estimated end date 2017-11-22 2017-11-03
Actual end date 2017-11-14
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments